BioSpace News Archive

Data demonstrate that UNITE, as a nucleic acid platform, may enhance antitumor immunity

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, today announced it has entered into a research and license agreement in which Astellas Pharma Inc. will access Xencor’s bispecific technology to advance a novel bispecific antibody program in oncology

Akoya Biosciences, Inc., today announced the appointment of Joseph Driscoll as Chief Financial Officer.

Noveome Biotherapeutics, Inc. announced that William J. Golden, Founder, Chairman and Chief Executive Officer of Noveome Biotherapeutics, Inc., will present a company overview at the 18th Annual Needham Healthcare Conference on Tuesday, April 9, 2019 at 10:20 a.m. EDT in New York, NY.

WellCare Health Plans, Inc. (NYSE: WCG), a leading provider of Medicaid, Medicare and Prescription Drug programs, announced today that the New York Department of Health has approved the expansion of WellCare of New York, Inc. into three additional counties.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, April 25, at 4:30 p.m. ET to discuss first quarter 2019 financial results and provide a general business update.

Topline data from ORCA-1 trial expected in the Second Quarter of 2019

Leading Men’s Health Charity Survey Shows More Than Half of Young Men Unaware of Risk

Report demonstrates the organization’s growth and impact on the disease

Expanded Roster of Expert Physicians Affiliated with America’s Leading Hospitals Now Available to Individuals Facing a Life-Changing Diagnosis